Lenalidomide

Lenalidomide (initially known as CC-5013 and marketed as Revlimid? by Celgene) is a derivative of thalidomide introduced in 2004.

191732-72-6

≥ 2 years

>98% (HPLC)

259.26

C13H13N3O3

Research use only, not for human use.

TNF-α

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

GB21403 100 μL

Ask

GTR15404087 1 Vial

Ask

APR32860G-01 50 µL

Ask

APR32860G-02 100 µL

Ask

APR32860G-03 200 µL

Ask

APR32860G-04 400 µL

Ask